Paul A. Gurbel, MD, is an associate professor of medicine at Johns Hopkins University School of Medicine, assistant professor of medicine at the University of Maryland School of Medicine, and director of the Sinai Center for Thrombosis Research and therapeutics, research, and technology development for the cardiac catheterization program at Sinai Hospital of Baltimore. He earned his medical degree from the University of Maryland, School of Medicine in Baltimore and completed an internship and residency in internal medicine at Duke University Medical Center in Durham, North Carolina. He completed a fellowship in pulmonary and critical care at Johns Hopkins Hospital followed by fellowships in cardiology and interventional cardiology at Duke University Medical Center. Dr Gurbel is board certified in internal medicine with subspecialty certification in cardiovascular disease and interventional cardiology. He is a manuscript reviewer of Arteriosclerosis, Thrombosis, and Vascular Biology; American Heart Journal; American Journal of Cardiology; Circulation; Journal of the American College of Cardiology; and Lancet. Dr Gurbel’s research interests include: thrombosis and vascular biology; innovations in catheter-based treatment of vascular disease; myocardial infarction treatment; platelet activation in heart disease; and antiplatelet therapy, mechanisms, and clinical effects of drug resistance. He has been the principal or co-investigator of over 50 clinical trials. Dr Gurbel has published articles in such journals as Circulation, The Journal of the American Medical Association, American Journal of Cardiology, American Heart Journal, Journal of the American College of Cardiology, and the New England Journal of Medicine.